Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial (Q36302775)

13 August 2017

Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

Gregory C Shearer

1

1 reference

13 August 2017

James V Pottala

2

1 reference

13 August 2017

Susan N Hansen

3

1 reference

13 August 2017

Verdayne Brandenburg

4

1 reference

13 August 2017

William S Harris

5

1 reference

13 August 2017

14 August 2012

1 reference

Journal of Lipid Research

13 August 2017

1 reference

13 August 2017

53

1 reference

13 August 2017

11

1 reference

13 August 2017

2429-2435

1 reference

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Omega-3 fatty acids vs. cardiac disease--the contribution of the omega-3 index

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Is it LDL particle size or number that correlates with risk for cardiovascular disease?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

n-3 fatty acids and lipoproteins: comparison of results from human and animal studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466011

Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects

29 June 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment dura

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

The Omega-3 Index: a new risk factor for death from coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P022392

Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria

21 January 2018

1 reference

12 December 2020

Safety and efficacy of Omacor in severe hypertriglyceridemia

1 reference

12 December 2020

Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients

1 reference

12 December 2020

The metabolic syndrome and the risk of venous thrombosis: a case–control study

1 reference

12 December 2020

Identifiers

DOI

10.1194/JLR.P022392

1 reference

13 August 2017

1 reference

13 August 2017

1 reference